stars 1 stars 2 stars 3

GenoSmart develops a novel and proprietary highly versatile bio-electronic molecular diagnostic device termed “Miniature Enthalpy-Meter (MEM)”, for the rapid and accurate diagnosis of pathogens such as: antibiotic resistant bacteria, pandemic viruses and bio-terror agents. Using this technology, we develop a rapid, affordable and easy-to-use diagnostic device for any site of need. The MEM platform detects the minute change in the kinetic energy of molecules, i.e. enthalpy rich specific molecular interactions such as DNA hybridization, enzyme-substrate reactions and antibody-antigen binding within minutes. GenoSmart has also developed a proprietary, cutting-edge, highly adaptable automatic nucleic acid purification system termed “Automated Nucleic Acid Extraction” (ANAE) device. The ANAE rapidly (within minutes) and efficiently purifies DNA or RNA from any source, be it biological, gel electrophoresis or other, in one automatic step. According to need, the separation process can be readily fitted with any market-accepted method such as bead, column or affinity based (or combined). Ensuing extraction, product can be post-processed by several enzymatic steps with temperatures ranging between sub-ambient to denaturation, to yield highly specific purified products. All ANAE processes are performed rapidly and automatically from start-to-finish.

GenoSmart Questions

Ofer Zohar is the Inventor, founder and CTO of GenoSmart.

2 people are employed at GenoSmart.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users